Inventurus Knowledge Solutions Limited (IKS) — Financial Results Announcement
📢 Key Event
IKS Health reported Q4 FY26 revenue of INR 8,577 million, up 5.2% YoY, with PAT margin at 33% and EBITDA of INR 3,002 million.
🔄 What Changed
PAT margin expanded to 33% and EBITDA reached INR 3,002 million, reflecting improved profitability and operational efficiency.
🔮 What's Next
The company highlighted plans to expand AI capabilities and pursue strategic acquisitions like TruBridge and ARAI to drive long-term growth and platform integration.
💡 Investor Takeaway
This performance demonstrates IKS Health's ability to grow revenue faster than the market while significantly improving margins through AI-driven efficiency and strategic client expansion.
IKS Health reported INR 8,577 million revenue for Q4 FY26, up 5.2% YoY, with PAT margin expanding to 33% and EBITDA reaching INR 3,002 million, reflecting strong growth and margin improvement driven by strategic client wins and AI platform adoption.
📄 View Original Announcement (PDF)
About Inventurus Knowledge Solutions Limited (IKS)
Information Technology · IT - Services · Listed on NSE
Market Cap: ₹27,371.07 Cr
P/E: 37.5
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.